ARPC1B and central nervous system cancer: Additionally, ARPC1B has been linked to radiotherapy resistance, as ARPC1B-deficient patients exhibit increased sensitivity to ionizing radiation and the drug bleomycin (10).Furthermore, the overexpression of ARPC1B has been shown to promote radiotherapy resistance and maintain mesenchymal phenotype in glioma stem cells (11).